Atezolizumab and nab-paclitaxel in advanced triple-negative breast cancer
Original Article from The New England Journal of Medicine - Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
October 20, 2018
|
| In: |
The New England journal of medicine
Year: 2018, Jahrgang: 379, Pages: 2108-2121 |
| ISSN: | 1533-4406 |
| DOI: | 10.1056/NEJMoa1809615 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1056/NEJMoa1809615 Verlag, lizenzpflichtig, Volltext: https://www.nejm.org/doi/10.1056/NEJMoa1809615 
|
| Verfasserangaben: | Peter Schmid, Sylvia Adams, Hope S. Rugo, Andreas Schneeweiss, Carlos H. Barrios, Hiroji Iwata, Véronique Diéras, Roberto Hegg, Seock-Ah Im, Gail Shaw Wright, Volkmar Henschel, Luciana Molinero, Stephen Y. Chui, Roel Funke, Amreen Husain, Eric P. Winer, Sherene Loi, and Leisha A. Emens, for the IMpassion130 Trial Investigators |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1695552725 | ||
| 003 | DE-627 | ||
| 005 | 20230426080114.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200421s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1056/NEJMoa1809615 |2 doi | |
| 035 | |a (DE-627)1695552725 | ||
| 035 | |a (DE-599)KXP1695552725 | ||
| 035 | |a (OCoLC)1341316133 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Schmid, Peter |d 1971- |e VerfasserIn |0 (DE-588)121696758 |0 (DE-627)081474032 |0 (DE-576)292835183 |4 aut | |
| 245 | 1 | 0 | |a Atezolizumab and nab-paclitaxel in advanced triple-negative breast cancer |c Peter Schmid, Sylvia Adams, Hope S. Rugo, Andreas Schneeweiss, Carlos H. Barrios, Hiroji Iwata, Véronique Diéras, Roberto Hegg, Seock-Ah Im, Gail Shaw Wright, Volkmar Henschel, Luciana Molinero, Stephen Y. Chui, Roel Funke, Amreen Husain, Eric P. Winer, Sherene Loi, and Leisha A. Emens, for the IMpassion130 Trial Investigators |
| 264 | 1 | |c October 20, 2018 | |
| 300 | |a 14 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a This article was published on October 20, 2018, and updated on November 15, 2018, at NEJM.org | ||
| 500 | |a Gesehen am 21.04.2020 | ||
| 520 | |a Original Article from The New England Journal of Medicine - Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer | ||
| 700 | 1 | |a Adams, Sylvia |e VerfasserIn |4 aut | |
| 700 | 1 | |a Rugo, Hope S. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schneeweiss, Andreas |d 1961- |e VerfasserIn |0 (DE-588)109972554 |0 (DE-627)632849630 |0 (DE-576)327251859 |4 aut | |
| 700 | 1 | |a Barrios, Carlos H. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Iwata, Hiroji |e VerfasserIn |4 aut | |
| 700 | 1 | |a Diéras, Véronique |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hegg, Roberto |e VerfasserIn |4 aut | |
| 700 | 1 | |a Im, Seock-Ah |e VerfasserIn |4 aut | |
| 700 | 1 | |a Wright, Gail Shaw |e VerfasserIn |4 aut | |
| 700 | 1 | |a Henschel, Volkmar |e VerfasserIn |4 aut | |
| 700 | 1 | |a Molinero, Luciana |e VerfasserIn |4 aut | |
| 700 | 1 | |a Chui, Stephen Y. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Funke, Roel |e VerfasserIn |4 aut | |
| 700 | 1 | |a Husain, Amreen |e VerfasserIn |4 aut | |
| 700 | 1 | |a Winer, Eric P. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Loi, Sherene |e VerfasserIn |4 aut | |
| 700 | 1 | |a Emens, Leisha A. |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The New England journal of medicine |d Waltham, Mass. : MMS, 1928 |g 379(2018), Seite 2108-2121 |h Online-Ressource |w (DE-627)266889484 |w (DE-600)1468837-2 |w (DE-576)075962454 |x 1533-4406 |7 nnas |a Atezolizumab and nab-paclitaxel in advanced triple-negative breast cancer |
| 773 | 1 | 8 | |g volume:379 |g year:2018 |g pages:2108-2121 |g extent:14 |a Atezolizumab and nab-paclitaxel in advanced triple-negative breast cancer |
| 856 | 4 | 0 | |u https://doi.org/10.1056/NEJMoa1809615 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.nejm.org/doi/10.1056/NEJMoa1809615 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20200421 | ||
| 993 | |a Article | ||
| 994 | |a 2018 | ||
| 998 | |g 109972554 |a Schneeweiss, Andreas |m 109972554:Schneeweiss, Andreas |d 910000 |d 910400 |e 910000PS109972554 |e 910400PS109972554 |k 0/910000/ |k 1/910000/910400/ |p 4 | ||
| 999 | |a KXP-PPN1695552725 |e 3628534615 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"origin":[{"dateIssuedDisp":"October 20, 2018","dateIssuedKey":"2018"}],"relHost":[{"part":{"extent":"14","pages":"2108-2121","text":"379(2018), Seite 2108-2121","volume":"379","year":"2018"},"language":["eng"],"pubHistory":["198.1928 -"],"note":["Gesehen am 04.08.25"],"corporate":[{"display":"Massachusetts Medical Society","role":"isb"}],"disp":"Atezolizumab and nab-paclitaxel in advanced triple-negative breast cancerThe New England journal of medicine","type":{"media":"Online-Ressource","bibl":"periodical"},"titleAlt":[{"title":"NEJM"}],"name":{"displayForm":["Massachusetts Medical Society"]},"recId":"266889484","id":{"eki":["266889484"],"issn":["1533-4406"],"zdb":["1468837-2"]},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"The New England journal of medicine","subtitle":"NEJM","title_sort":"New England journal of medicine"}],"origin":[{"dateIssuedKey":"1928","publisherPlace":"Waltham, Mass. ; Boston, Mass.","publisher":"MMS ; MMS","dateIssuedDisp":"1928-"}]}],"physDesc":[{"extent":"14 S."}],"id":{"eki":["1695552725"],"doi":["10.1056/NEJMoa1809615"]},"title":[{"title_sort":"Atezolizumab and nab-paclitaxel in advanced triple-negative breast cancer","title":"Atezolizumab and nab-paclitaxel in advanced triple-negative breast cancer"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["This article was published on October 20, 2018, and updated on November 15, 2018, at NEJM.org","Gesehen am 21.04.2020"],"person":[{"display":"Schmid, Peter","given":"Peter","role":"aut","family":"Schmid"},{"family":"Adams","role":"aut","display":"Adams, Sylvia","given":"Sylvia"},{"given":"Hope S.","display":"Rugo, Hope S.","role":"aut","family":"Rugo"},{"role":"aut","family":"Schneeweiss","display":"Schneeweiss, Andreas","given":"Andreas"},{"role":"aut","family":"Barrios","given":"Carlos H.","display":"Barrios, Carlos H."},{"display":"Iwata, Hiroji","given":"Hiroji","family":"Iwata","role":"aut"},{"role":"aut","family":"Diéras","given":"Véronique","display":"Diéras, Véronique"},{"given":"Roberto","display":"Hegg, Roberto","role":"aut","family":"Hegg"},{"display":"Im, Seock-Ah","given":"Seock-Ah","role":"aut","family":"Im"},{"family":"Wright","role":"aut","display":"Wright, Gail Shaw","given":"Gail Shaw"},{"given":"Volkmar","display":"Henschel, Volkmar","role":"aut","family":"Henschel"},{"family":"Molinero","role":"aut","given":"Luciana","display":"Molinero, Luciana"},{"display":"Chui, Stephen Y.","given":"Stephen Y.","family":"Chui","role":"aut"},{"family":"Funke","role":"aut","display":"Funke, Roel","given":"Roel"},{"family":"Husain","role":"aut","display":"Husain, Amreen","given":"Amreen"},{"display":"Winer, Eric P.","given":"Eric P.","role":"aut","family":"Winer"},{"family":"Loi","role":"aut","display":"Loi, Sherene","given":"Sherene"},{"given":"Leisha A.","display":"Emens, Leisha A.","family":"Emens","role":"aut"}],"recId":"1695552725","language":["eng"],"name":{"displayForm":["Peter Schmid, Sylvia Adams, Hope S. Rugo, Andreas Schneeweiss, Carlos H. Barrios, Hiroji Iwata, Véronique Diéras, Roberto Hegg, Seock-Ah Im, Gail Shaw Wright, Volkmar Henschel, Luciana Molinero, Stephen Y. Chui, Roel Funke, Amreen Husain, Eric P. Winer, Sherene Loi, and Leisha A. Emens, for the IMpassion130 Trial Investigators"]}} | ||
| SRT | |a SCHMIDPETEATEZOLIZUM2020 | ||